Literature DB >> 18217166

Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.

Marianne Canonico, Valérie Olié, Laure Carcaillon, Pascale Tubert-Bitter, Pierre-Yves Scarabin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18217166     DOI： 10.1160/TH07-09-0536

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

1.  Inference for additive interaction under exposure misclassification.

Authors:  Tyler J Vanderweele
Journal:  Biometrika       Date:  2012-04-02       Impact factor: 2.445

Review 2.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

3.  Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy.

Authors:  M Blondon; K L Wiggins; L B Harrington; B M Psaty; N L Smith
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

4.  ABO blood types associated with the risk of venous thromboembolism in Han Chinese people: A hospital-based study of 200,000 patients.

Authors:  Xuefeng Sun; Jun Feng; Wei Wu; Min Peng; Juhong Shi
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

5.  Biomarkers, menopausal hormone therapy and risk of venous thrombosis: The Women's Health Initiative.

Authors:  Mary Cushman; Joseph C Larson; Frits R Rosendaal; Susan R Heckbert; J David Curb; Lawrence S Phillips; Alison E Baird; Charles B Eaton; Randall S Stafford
Journal:  Res Pract Thromb Haemost       Date:  2018-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.